* A phase 3 study of GS-5745 is ongoing in patients with
Gastric Cancer
The post BRIEF-Gilead terminates phase 2/3 study of GS-5745 in patients with Ulcerative Colitis appeared first on NASDAQ.
Forex – financial instrument.Forex news
* A phase 3 study of GS-5745 is ongoing in patients with
Gastric Cancer
The post BRIEF-Gilead terminates phase 2/3 study of GS-5745 in patients with Ulcerative Colitis appeared first on NASDAQ.